Reteplase ( rPA ) for Injection
[Dosage Form] Freeze-dried powder for injection.
[Indications]
Indicated for use in the management of acute myocardial infarction in adults for the improvement of ventricular function following AMI .
[Highlights]
Retaplase is the third generation thrombolytic drug, compared with Activase (Alteplase) from Boehringer Ingelheim GmbH, the second generation thrombolytic drug
Retaplase has the advantages below:
• More convenient administration
• Less dosage
• Less adverse reaction
